Dilemmas in the Dosing of Heart Failure Drugs: Titrating Diuretics in Chronic Heart Failure

Overview

Journal Card Fail Rev

Date 2018 Feb 2

PMID 29387462

Citations 5

Authors

David Pham

Justin L Grodin

Affiliations

Soon will be listed here.

Abstract

Despite advances in medical therapy over the past few decades, the incidence of heart failure hospitalisation continues to rise. Diuretics are the most common therapy used to treat heart failure as they relieve congestion. However, there is a lack of guidance on how to best use these medications. Guidelines support the use of diuretics at the lowest clinically effective dose but do not specify a diuretic strategy beyond that. Here we review the diuretics available for treatment, potential mechanisms of diuretic resistance and ways to address this in the ambulatory setting, and review tools that have been developed to help guide diuretic use in the treatment of chronic heart failure.

Citing Articles

Advanced Hemodynamic Monitoring Allows Recognition of Early Response Patterns to Diuresis in Congestive Heart Failure Patients.

Dagan M, Kolben Y, Goldstein N, Ben Ishay A, Fons M, Merin R J Clin Med. 2023; 12(1).

PMID: 36614848 PMC: 9821287. DOI: 10.3390/jcm12010045.

Relation between Mid-Regional Pro-Adrenomedullin in Patients with Chronic Heart Failure and the Dose of Diuretics in 2-Year Follow-Up-Data from FAR NHL Registry.

Spinarova M, Spinar J, Spinarova L, Krejci J, Goldbergova-Pavkova M, Parenica J Medicina (Kaunas). 2022; 58(10).

PMID: 36295637 PMC: 9611464. DOI: 10.3390/medicina58101477.

A novel strategy to reduce the readmission rates in congestive heart failure: intermittent empirical intravenous diuretics.

Yetkin E, Cuglan B, Turhan H, Ozturk S Cardiovasc Endocrinol Metab. 2020; 9(2):60-63.

PMID: 32537567 PMC: 7228777. DOI: 10.1097/XCE.0000000000000200.

Renal function, electrolytes, and congestion monitoring in heart failure.

Rossignol P, Coats A, Chioncel O, Spoletini I, Rosano G Eur Heart J Suppl. 2020; 21(Suppl M):M25-M31.

PMID: 31908612 PMC: 6937505. DOI: 10.1093/eurheartj/suz220.

Identifying Adverse Drug Events in Older Community-Dwelling Patients.

Cahir C, Wallace E, Cummins A, Teljeur C, Byrne C, Bennett K Ann Fam Med. 2019; 17(2):133-140.

PMID: 30858256 PMC: 6411408. DOI: 10.1370/afm.2359.

References

Konecke L . Clinical trial of bumetanide versus furosemide in patients with congestive heart failure. J Clin Pharmacol. 1981; 21(11):688-90. DOI: 10.1002/j.1552-4604.1981.tb05684.x. View

Ter Maaten J, Dunning A, Valente M, Damman K, Ezekowitz J, Califf R . Diuretic response in acute heart failure-an analysis from ASCEND-HF. Am Heart J. 2015; 170(2):313-21. DOI: 10.1016/j.ahj.2015.05.003. View

van Vliet A, Donker A, Nauta J, Verheugt F . Spironolactone in congestive heart failure refractory to high-dose loop diuretic and low-dose angiotensin-converting enzyme inhibitor. Am J Cardiol. 1993; 71(3):21A-28A. DOI: 10.1016/0002-9149(93)90241-4. View

Hensen J, Abraham W, Durr J, Schrier R . Aldosterone in congestive heart failure: analysis of determinants and role in sodium retention. Am J Nephrol. 1991; 11(6):441-6. DOI: 10.1159/000168356. View

Voelker J, Anderson S, Leinfelder J, Sica D, Kokko J, Brater D . Comparison of loop diuretics in patients with chronic renal insufficiency. Kidney Int. 1987; 32(4):572-8. DOI: 10.1038/ki.1987.246. View

Goenaga M, Millet M, Sanchez E, Garde C, Carrera J, Arzellus E . Subcutaneous furosemide. Ann Pharmacother. 2004; 38(10):1751. DOI: 10.1345/aph.1E172. View

Buckley L, Carter D, Matta L, Cheng J, Stevens C, Belenkiy R . Intravenous Diuretic Therapy for the Management of Heart Failure and Volume Overload in a Multidisciplinary Outpatient Unit. JACC Heart Fail. 2015; 4(1):1-8. DOI: 10.1016/j.jchf.2015.06.017. View

Valente M, Voors A, Damman K, Van Veldhuisen D, Massie B, OConnor C . Diuretic response in acute heart failure: clinical characteristics and prognostic significance. Eur Heart J. 2014; 35(19):1284-93. DOI: 10.1093/eurheartj/ehu065. View

Zannad F, McMurray J, Krum H, Van Veldhuisen D, Swedberg K, Shi H . Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med. 2010; 364(1):11-21. DOI: 10.1056/NEJMoa1009492. View

10.

BEERMANN B, Midskov C . Reduced bioavailability and effect of furosemide given with food. Eur J Clin Pharmacol. 1986; 29(6):725-7. DOI: 10.1007/BF00615967. View

11.

Makadia S, Simmons T, Augustine S, Kovell L, Harris C, Chibungu A . The diuresis clinic: a new paradigm for the treatment of mild decompensated heart failure. Am J Med. 2015; 128(5):527-31. DOI: 10.1016/j.amjmed.2014.11.028. View

12.

Abraham W, Adamson P, Bourge R, Aaron M, Costanzo M, Stevenson L . Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet. 2011; 377(9766):658-66. DOI: 10.1016/S0140-6736(11)60101-3. View

13.

Konstam M, Kiernan M, Chandler A, Dhingra R, Mody F, Eisen H . Short-Term Effects of Tolvaptan in Patients With Acute Heart Failure and Volume Overload. J Am Coll Cardiol. 2017; 69(11):1409-1419. DOI: 10.1016/j.jacc.2016.12.035. View

14.

Whellan D, Ousdigian K, Al-Khatib S, Pu W, Sarkar S, Porter C . Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients.... J Am Coll Cardiol. 2010; 55(17):1803-10. DOI: 10.1016/j.jacc.2009.11.089. View

15.

Butler J, Anstrom K, Felker G, Givertz M, Kalogeropoulos A, Konstam M . Efficacy and Safety of Spironolactone in Acute Heart Failure: The ATHENA-HF Randomized Clinical Trial. JAMA Cardiol. 2017; 2(9):950-958. PMC: 5675712. DOI: 10.1001/jamacardio.2017.2198. View

16.

Gottlieb S, Khatta M, Wentworth D, Roffman D, Fisher M, Kramer W . The effects of diuresis on the pharmacokinetics of the loop diuretics furosemide and torsemide in patients with heart failure. Am J Med. 1998; 104(6):533-8. DOI: 10.1016/s0002-9343(98)00111-9. View

17.

Bowman B, Nawarskas J, Anderson J . Treating Diuretic Resistance: An Overview. Cardiol Rev. 2016; 24(5):256-60. DOI: 10.1097/CRD.0000000000000116. View

18.

Huerta C, Varas-Lorenzo C, Castellsague J, Garcia Rodriguez L . Non-steroidal anti-inflammatory drugs and risk of first hospital admission for heart failure in the general population. Heart. 2006; 92(11):1610-5. PMC: 1861219. DOI: 10.1136/hrt.2005.082388. View

19.

Yu C, Wang L, Chau E, Chan R, Kong S, Tang M . Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation. 2005; 112(6):841-8. DOI: 10.1161/CIRCULATIONAHA.104.492207. View

20.

Vargo D, Kramer W, Black P, Smith W, Serpas T, Brater D . Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure. Clin Pharmacol Ther. 1995; 57(6):601-9. DOI: 10.1016/0009-9236(95)90222-8. View